TP53 and central nervous system cancer: More specifically, approximately 10% (of hematopoietic malignancies) to 50–70% of all other human cancers are found to have somatic mutations in the p53 gene [33], with approximately 25% of gliomas carrying mutations in the p53 gene [34].